Page last updated: 2024-09-05

maropitant and Vomiting

maropitant has been researched along with Vomiting in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (30.77)29.6817
2010's15 (57.69)24.3611
2020's3 (11.54)2.80

Authors

AuthorsStudies
Burke, JE; Hess, RS; Silverstein, DC1
Fukazawa, E; Harada, K; Ichimata, M; Kobayashi, T; Matsuyama, F; Nakano, Y1
Bettschart-Wolfensberger, R; Hartnack, S; Kantyka, ME; Kutter, APN; Meira, C1
Cartagena-Albertus, JC; Engel Manchado, J; Moise, A; Montoya Alonso, JA; Moya García, S1
Johnson, RA1
Cooke, K; Isaza, N; Koh, RB; Robertson, SA; Xie, H1
Hay Kraus, BL3
Bolotin, D; Brock, WT; Moses, K; Patricelli, K; Quimby, JM1
Himelfarb, MA; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP1
Boesch, JM; Campoy, L; Gleed, RD; Kirch, PJ; Learn, MM; Martin-Flores, M; Mastrocco, A; Sakai, DM1
Boesch, JM; Campoy, L; Gleed, RD; Learn, MM; Martin-Flores, M; Mastrocco, A; Sakai, DM1
Himelfarb, MA; Invaldi, SH; Litterio, NJ; Lorenzutti, AM; Martín-Flores, M; Zarazaga, MP1
Keser, GO; Yalcin, E1
Boucher, JF; Clemence, RG; Conder, GA; Sedlacek, HS1
Boucher, JF; Clemence, RG; Conder, GA; Eagleson, JS; Ramsey, DS; Sedlacek, HS1
Boucher, JF; Clemence, RG; Conder, GA; Eagleson, JS; Kincaid, K; Ramsey, DS; Watkins, JA1
Trepanier, L1
Shukla, A1
Alibhai, HI; Lee, K; Mathis, A1
Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Tilt, N1
Benchaoui, HA; Clemence, RG; de la Puente-Redondo, VA; Rowan, TG; Siedek, EM; Tilt, N2
van Noort, R1
Bunger, A; Cox, SR; Hickman, MA; Lin, J; Mahabir, S; McCall, RB; Miskell, C1

Reviews

1 review(s) available for maropitant and Vomiting

ArticleYear
Acute vomiting in cats: rational treatment selection.
    Journal of feline medicine and surgery, 2010, Volume: 12, Issue:3

    Topics: Acute Disease; Animals; Antiemetics; Cat Diseases; Cats; Chlorpromazine; Diarrhea; Famotidine; Indoles; Metoclopramide; Nausea; Ondansetron; Prochlorperazine; Quinolizines; Quinuclidines; Ranitidine; Sucralfate; Vomiting; Weight Loss

2010

Trials

17 trial(s) available for maropitant and Vomiting

ArticleYear
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
    Journal of the American Veterinary Medical Association, 2021, 12-15, Volume: 260, Issue:S1

    Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Glycopyrrolate; Hydromorphone; Nausea; Ondansetron; Quinuclidines; Vomiting

2021
Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
    Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2020, Volume: 30, Issue:4

    Topics: Animals; Antiemetics; Antifibrinolytic Agents; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Ondansetron; Prospective Studies; Quinuclidines; Tranexamic Acid; Vomiting

2020
Assessment of the administration of maropitant and loperamide to dogs with cancer for the prevention and reduction of adverse effects associated with the administration of paclitaxel.
    American journal of veterinary research, 2019, Volume: 80, Issue:6

    Topics: Animals; Antidiarrheals; Antiemetics; Antineoplastic Agents, Phytogenic; Diarrhea; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Loperamide; Male; Neoplasms; Paclitaxel; Quinuclidines; Random Allocation; Vomiting

2019
Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone.
    Veterinary anaesthesia and analgesia, 2014, Volume: 41, Issue:4

    Topics: Acepromazine; Analgesics, Opioid; Anesthesia, Inhalation; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Esophagus; Female; Gastroesophageal Reflux; Hydrogen-Ion Concentration; Hydromorphone; Male; Quinuclidines; Vomiting

2014
Effects of maropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs.
    Journal of the American Veterinary Medical Association, 2014, Apr-01, Volume: 244, Issue:7

    Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Dopamine Antagonists; Electroacupuncture; Female; Male; Morphine; Quinuclidines; Vomiting

2014
Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
    Journal of the American Veterinary Medical Association, 2014, May-15, Volume: 244, Issue:10

    Topics: Administration, Oral; Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Male; Quinuclidines; Vomiting

2014
Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
    Journal of the American Veterinary Medical Association, 2014, Nov-01, Volume: 245, Issue:9

    Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Drug Administration Schedule; Female; Hydromorphone; Male; Nausea; Quinuclidines; Vomiting

2014
Chronic use of maropitant for the management of vomiting and inappetence in cats with chronic kidney disease: a blinded, placebo-controlled clinical trial.
    Journal of feline medicine and surgery, 2015, Volume: 17, Issue:8

    Topics: Animals; Cat Diseases; Cats; Double-Blind Method; Kidney Function Tests; Palliative Care; Quinuclidines; Renal Insufficiency, Chronic; Vomiting

2015
Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine.
    Veterinary anaesthesia and analgesia, 2016, Volume: 43, Issue:2

    Topics: Acepromazine; Analgesics, Opioid; Animals; Antiemetics; Dogs; Drug Interactions; Female; Male; Morphine; Prospective Studies; Quinuclidines; Salivation; Single-Blind Method; Vomiting

2016
Evaluation of oral maropitant as an antiemetic in cats receiving morphine and dexmedetomidine.
    Journal of feline medicine and surgery, 2016, Volume: 18, Issue:11

    Topics: Administration, Oral; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Antiemetics; Cats; Dexmedetomidine; Female; Hysterectomy; Morphine; Ovariectomy; Prospective Studies; Quinuclidines; Treatment Outcome; Vomiting

2016
Effects of maropitant in cats receiving dexmedetomidine and morphine.
    Journal of the American Veterinary Medical Association, 2016, Jun-01, Volume: 248, Issue:11

    Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Antiemetics; Cat Diseases; Cats; Dexmedetomidine; Drug Interactions; Female; Injections, Intramuscular; Injections, Subcutaneous; Morphine; Nausea; Quinuclidines; Single-Blind Method; Visual Analog Scale; Vomiting

2016
A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2017, Volume: 58, Issue:1

    Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hysterectomy; Male; Metoclopramide; Morphine; Nausea; Orchiectomy; Ovariectomy; Quinuclidines; Vomiting

2017
Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
    Journal of veterinary pharmacology and therapeutics, 2017, Volume: 40, Issue:6

    Topics: Animals; Antiemetics; Dog Diseases; Dogs; Female; Male; Metoclopramide; Ondansetron; Parvoviridae Infections; Parvovirus, Canine; Quinuclidines; Treatment Outcome; Vomiting

2017
Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
    Veterinary anaesthesia and analgesia, 2013, Volume: 40, Issue:1

    Topics: Analgesics, Opioid; Animals; Antiemetics; Dog Diseases; Dogs; Female; Hydromorphone; Injections, Intramuscular; Male; Preanesthetic Medication; Quinuclidines; Vomiting

2013
Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
    American journal of veterinary research, 2007, Volume: 68, Issue:1

    Topics: Administration, Oral; Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dog Diseases; Dogs; Female; Least-Squares Analysis; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting

2007
The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
    The Journal of small animal practice, 2007, Volume: 48, Issue:2

    Topics: Animals; Antiemetics; Dog Diseases; Dogs; Europe; Female; Male; Quinuclidines; Treatment Outcome; Vomiting

2007
Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs.
    The Veterinary record, 2007, Sep-29, Volume: 161, Issue:13

    Topics: Animals; Antiemetics; Cross-Over Studies; Dog Diseases; Dogs; Double-Blind Method; Female; Male; Motion Sickness; Quinuclidines; Treatment Outcome; Vomiting

2007

Other Studies

8 other study(ies) available for maropitant and Vomiting

ArticleYear
Evaluation of adverse events in small-breed dogs treated with maropitant and a single dose of doxorubicin.
    Journal of veterinary internal medicine, 2022, Volume: 36, Issue:4

    Topics: Animals; Diarrhea; Dog Diseases; Dogs; Doxorubicin; Neoplasms; Neutropenia; Prospective Studies; Quinuclidines; Vomiting

2022
Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.
    Journal of veterinary pharmacology and therapeutics, 2008, Volume: 31, Issue:6

    Topics: Animals; Cross-Over Studies; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Male; Motion Sickness; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting

2008
Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
    Journal of veterinary pharmacology and therapeutics, 2008, Volume: 31, Issue:6

    Topics: Animals; Apomorphine; Cross-Over Studies; Dogs; Emetics; Humans; Ipecac; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting

2008
Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.
    Journal of veterinary pharmacology and therapeutics, 2008, Volume: 31, Issue:6

    Topics: Administration, Oral; Animals; Dogs; Drug-Related Side Effects and Adverse Reactions; Female; Injections, Subcutaneous; Male; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting

2008
Acute pancreatitis attributed to dietary indiscretion in a female mixed breed canine.
    The Canadian veterinary journal = La revue veterinaire canadienne, 2010, Volume: 51, Issue:2

    Topics: Acute Disease; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cell Count; Dehydration; Dog Diseases; Dogs; Female; Medical History Taking; Meloxicam; Pancreatitis; Quinuclidines; Radiography; Tachycardia; Thiazines; Thiazoles; Treatment Outcome; Vomiting

2010
The use of maropitant to prevent vomiting induced by epidural administration of preservative free morphine through an epidural catheter in a dog.
    Veterinary anaesthesia and analgesia, 2011, Volume: 38, Issue:5

    Topics: Anesthesia, Epidural; Animals; Antiemetics; Dog Diseases; Dogs; Male; Morphine; Narcotics; Quinuclidines; Vomiting

2011
[New antiemetics: maropitant citrate].
    Tijdschrift voor diergeneeskunde, 2007, May-15, Volume: 132, Issue:10

    Topics: Animals; Antiemetics; Quinuclidines; Vomiting

2007
Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats.
    Journal of veterinary pharmacology and therapeutics, 2008, Volume: 31, Issue:3

    Topics: Animals; Cats; Female; Male; Metabolic Clearance Rate; Motion Sickness; Neurokinin-1 Receptor Antagonists; Quinuclidines; Vomiting

2008